Memorial Sloan Kettering Cancer Center
Myeloma
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "The Best of Myeloma - Review of the Top 5 Abstracts"
FEATURING
Hamza Hashmi
- 616 views
- July 1, 2024
- 5
Memorial Sloan Kettering Cancer Center
ASTCT Survey on Management of R/R Myeloma Patients After Failure by CAR-T
FEATURING
Hamza Hashmi
- 142 views
- May 21, 2024
- 1
Memorial Sloan Kettering Cancer Center
Key Myeloma & MGUS Updates From ASH
FEATURING
Sham Mailankody
- 326 views
- May 2, 2024
- 2
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "The Best of Myeloma - Highlights & Key Takeaways"
FEATURING
Hamza Hashmi
- 1,585 views
- January 19, 2024
- 6
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Frontline Treatment for High-Risk MM - Personalized?
FEATURING
Saad Usmani
- 228 views
- October 18, 2023
- 1
Indy Hematology Review
Managing Newly Diagnosed MM in 2023
FEATURING
Saad Usmani
- 250 views
- April 19, 2023
Indy Hematology Review
DEBATE: Transplanting the MRD- Myeloma Patients for a Deeper Remission After Initial Therapy
FEATURING
Saad Usmani
- 335 views
- April 19, 2023
- 1
ASH 2022 Conference Coverage
ASH 2022 Maintenance Therapy Cessation for Sustained MRD Negative MM Patients
FEATURING
Neha Korde
- 413 views
- December 21, 2022
- 2
2022 Community Oncology Conference
Treatment Conundrums in Myeloma
FEATURING
Sergio Giralt
- 501 views
- June 7, 2022
- 4
Rush University Medical Center
High-Risk Myeloma: Failures and Future Directions
FEATURING
Saad Usmani
- 79 views
- May 27, 2022
Memorial Sloan Kettering Cancer Center
Aiming for Minimal Residual Disease Negative Status in all Myeloma Patients
FEATURING
Ola Landgren
- 375 views
- May 11, 2018
- 1
Memorial Sloan Kettering Cancer Center
Should Smoldering Myeloma Be Treated?
FEATURING
Ola Landgren
- 1,093 views
- March 29, 2018
- 3
Memorial Sloan Kettering Cancer Center
Common Symptoms and Presentations of Multiple Myeloma to Primary Care Physicians
FEATURING
Ola Landgren
- 140 views
- February 16, 2018